Results 211 to 220 of about 60,819 (286)
Physical activity and testicular cancer survivorship health-related quality of life: a scoping review. [PDF]
Rovito MJ+9 more
europepmc +1 more source
FH immunohistochemistry is recommended in clinically malignant Leydig cell tumours and in primary Leydig cell tumours with aggressive histopathologic features. Aims Testicular sex cord‐stromal tumours (TSCSTs) are relatively rare, accounting for ~5% of all testicular neoplasms.
Andres M Acosta+21 more
wiley +1 more source
Low-cord orchidectomy for testicular cancer: what would be different? [PDF]
Sarıkaya EA+3 more
europepmc +1 more source
Three Cases of Multiple Primary Cancer in patients with Testicular Tumor.
Masaru Hasumi+3 more
openalex +2 more sources
PARP Inhibitors in Genitourinary Cancer: A New Paradigm Beyond Prostate Cancer
ABSTRACT Alterations in the homologous recombination repair genes, such as BRCA1 and BRCA2, are prevalent in various cancers, presenting a unique opportunity to develop synthetic lethal strategies that target homologous recombination deficiency (HRD).
Yohei Okuda+8 more
wiley +1 more source
Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case report. [PDF]
van Creij NCH+11 more
europepmc +1 more source
ABSTRACT Introduction Retroperitoneal lymph node dissection (RPLND) may be considered after chemotherapy or as primary treatment in patients with metastatic testicular cancer. We aimed to perform a systematic review to analyze outcomes in survivors across the domains of sexual, physical, and psychological function.
Gavin G. Calpin+4 more
wiley +1 more source
Rare Presentation of Testicular Cancer With Malignant Tumor Thrombus: A Case Report. [PDF]
Khushaym AH, Aljeeran N, Alabbasi L.
europepmc +1 more source
Insurance remains a major source of disparity for patients with testicular cancer: call for advocacy. [PDF]
Starr S+7 more
europepmc +1 more source